Metoprolol to Reduce Perioperative Myocardial Injury
Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test if a commonly used, FDA-approved medication,
called metoprolol, given during and after surgery, reduces the possibility of heart related
complications in patients with CAD.